Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03226808 · ClinicalTrials.gov registry record · NA
Vivacit-E Post-market Follow-up Study
A NA study of Osteoarthritis and Post-traumatic; Arthrosis, sponsored by Zimmer Biomet.
- Active
- Registry status
- NA
- Development phase
- 258
- Enrollment target
- 5
- Study locations
NCT03226808: Active NA study of Osteoarthritis and Post-traumatic; Arthrosis, sponsored by Zimmer Biomet.
NCT03226808 is a NA study of Osteoarthritis and Post-traumatic; Arthrosis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 258 participants, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (68% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03226808, a NA study of Osteoarthritis and Post-traumatic; Arthrosis, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 258 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objectives of this study are to obtain clinical performance (outcomes) data and survivorship for commercially available Vivacit-E (HXPE) liners. This will be done by analysis of polyethylene wear, validated outcome measurement tools, radiographs, and reported adverse events data.
Primary Outcome
Survival is classified as removal of the study device for any reason
Conditions Studied
Interventions
- DEVICE Vivacit-E Liner
Study Locations (5)
North Carolina
- Department of Orthopaedics University of North Carolina at Chapel Hill - Chapel Hill
- OrthoCarolina Research Institute - Charlotte
Colorado
- Denver Hip and Knee, Inc. - Parker
Pennsylvania
- Rothman Institute - Philadelphia
Texas
- Texas Institute for Hip and Knee Surgery - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2013-10-01 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What the registry record for NCT03226808 still lists
NCT03226808 is an interventional study that assigns participants to a tested intervention. The registered 258 participants enrollment target is mid-sized for trials with a published cap, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (68% lower).
The record links to 4 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Vivacit-E Liner is the first listed.
NCT03226808 lists 5 locations in 4 states (North Carolina, Colorado, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT03226808 about?
NCT03226808 is a clinical study titled "Vivacit-E Post-market Follow-up Study". The objectives of this study are to obtain clinical performance (outcomes) data and survivorship for commercially available Vivacit-E (HXPE) liners. This will be done by analysis of polyethylene wear, validated outcome measurement tools, radiographs, and reported adverse events data.
What is the current status of trial NCT03226808?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 258 participants. The study started on 2013-10-01. Estimated completion is 2028-06-30.
What conditions does trial NCT03226808 study?
This clinical trial studies the following conditions: Osteoarthritis, Post-traumatic; Arthrosis, Congenital Hip Dysplasia, Avascular Necrosis of Bone of Hip.
What interventions are being tested in trial NCT03226808?
The interventions under investigation include: Vivacit-E Liner (DEVICE).
Who is sponsoring clinical trial NCT03226808?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03226808 being conducted?
This trial has 5 study locations across Colorado, North Carolina, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03226808's enrollment target sits among peer trials
258 45th of 135 higher than 91 of 135 other Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy
RECRUITING · NA
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
Conversations in Health Literacy Using AI Technology for Osteoarthritis Patients
RECRUITING · NA
-
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03785288 · 258 participants · Phase 3
Vaginal Cuff Brachytherapy Fractionation Study
- NCT04643002 · 258 participants · Phase 1
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
- NCT04924322 · 258 participants · Phase 2
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- NCT05043012 · 258 participants · NA
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI